These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2582711)

  • 21. Pharmacodynamic modeling of the acid inhibitory effect of ranitidine in patients in an intensive care unit during prolonged dosing: characterization of tolerance.
    Mathôt RA; Geus WP
    Clin Pharmacol Ther; 1999 Aug; 66(2):140-51. PubMed ID: 10460068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of fasting on 24-h gastric secretion of patients with duodenal ulcers resistant to ranitidine.
    Johnston DA; Wormsley KG
    Aliment Pharmacol Ther; 1989 Oct; 3(5):471-9. PubMed ID: 2518860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of 6-hourly intermittent intravenous boluses of oxmetidine and ranitidine on gastric acidity and serum prolactin.
    Fölsch UR; Wichmann GC; Torossian A
    Eur J Clin Pharmacol; 1987; 33(3):267-71. PubMed ID: 2891536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circadian differences in pharmacological blockade of meal-stimulated gastric acid secretion.
    Sanders SW; Moore JG; Day GM; Tolman KG
    Aliment Pharmacol Ther; 1992 Apr; 6(2):187-93. PubMed ID: 1600040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of repeated boluses of intravenous omeprazole and primed infusions of ranitidine on 24-hour intragastric pH in healthy human subjects.
    Teyssen S; Chari ST; Scheid J; Singer MV
    Dig Dis Sci; 1995 Feb; 40(2):247-55. PubMed ID: 7851185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the effect of intermittent administration and continuous infusion of famotidine on gastric pH in critically ill patients: results of a prospective, randomized, crossover study.
    Baghaie AA; Mojtahedzadeh M; Levine RL; Fromm RE; Guntupalli KK; Opekun AR
    Crit Care Med; 1995 Apr; 23(4):687-91. PubMed ID: 7712759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evaluation of intravenous ranitidine and omeprazole effect on the 24-hour gastric ph-metry in duodenal ulcer hemorrhage].
    Artal A; Lanas A; Barrao ME; Moliner FJ; Blas JM; López J
    Rev Esp Enferm Dig; 1996 Mar; 88(3):191-6. PubMed ID: 8645512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective comparison of the effects of placebo, ranitidine and highly selective vagotomy on 24 h ambulatory intragastric pH in patients with duodenal ulcer.
    Rogers MJ; Holmfield JH; Primrose JN; Gledhill T; Johnston D
    Br J Surg; 1988 Oct; 75(10):961-5. PubMed ID: 3219542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single dose ranitidine: influence of the time of administration on gastric acidity in normal subjects and in patients with duodenal ulcer.
    Coppens JP; Warzee P; Schapira M; Fiasse R; Dive C
    Gastroenterol Clin Biol; 1988; 12(6-7):537-41. PubMed ID: 3417080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Control and variability of gastric pH in critically ill children.
    Gedeit RG; Weigle CG; Havens PL; Werlin SL
    Crit Care Med; 1993 Dec; 21(12):1850-5. PubMed ID: 8252889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of intravenous ranitidine on the intragastric pH of preterm infants receiving dexamethasone.
    Kelly EJ; Chatfield SL; Brownlee KG; Ng PC; Newell SJ; Dear PR; Primrose JN
    Arch Dis Child; 1993 Jul; 69(1 Spec No):37-9. PubMed ID: 8346951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maintenance of gastric pH above 6 with intravenous famotidine in patients with a bleeding duodenal ulcer.
    Delchier JC; el Amine I; Roudot-Thoraval F; Elouaer-Blanc L; Lamarque D; Stanescu L
    Aliment Pharmacol Ther; 1995 Apr; 9(2):191-6. PubMed ID: 7605861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of primed infusions with high dose ranitidine and omeprazole to maintain high intragastric pH in patients with peptic ulcer bleeding: a prospective randomised controlled study.
    Labenz J; Peitz U; Leusing C; Tillenburg B; Blum AL; Börsch G
    Gut; 1997 Jan; 40(1):36-41. PubMed ID: 9155573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Do continuous infusions of omeprazole and ranitidine retain their effect with prolonged dosing?
    Merki HS; Wilder-Smith CH
    Gastroenterology; 1994 Jan; 106(1):60-4. PubMed ID: 8276209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single morning and nightly doses of ranitidine 300 mg: an appraisal of their antisecretory effects by continuous pH monitoring.
    Savarino V; Mela GS; Zentilin P; Sumberaz A; Cutela P; Celle G
    Digestion; 1991; 48(3):141-8. PubMed ID: 1916034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the effects of placebo, ranitidine, famotidine and nizatidine on intragastric acidity by means of continuous pH recording.
    Savarino V; Mela GS; Zentilin P; Scalabrini P; Bonifacino G; Gambaro P; Celle G
    Digestion; 1989; 42(1):1-6. PubMed ID: 2568299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effectiveness of ranitidine in reducing gastric acid-secretion decreases with continued therapy.
    Prichard PJ; Jones DB; Yeomans ND; Mihaly GW; Smallwood RA; Louis WJ
    Br J Clin Pharmacol; 1986 Dec; 22(6):663-8. PubMed ID: 3567013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single nocturnal dose of an H2 receptor antagonist for the treatment of duodenal ulcer.
    Gledhill T; Howard OM; Buck M; Paul A; Hunt RH
    Gut; 1983 Oct; 24(10):904-8. PubMed ID: 6311692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of two intravenous ranitidine regimens in a homogeneous population of intensive care unit patients.
    Geus WP; Vinks AA; Smith SJ; Westra P; Lamers CB
    Aliment Pharmacol Ther; 1993 Aug; 7(4):451-7. PubMed ID: 8218759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic determination of ranitidine pharmacodynamics in pediatric ulcer disease.
    Blumer JL; Rothstein FC; Kaplan BS; Yamashita TS; Eshelman FN; Myers CM; Reed MD
    J Pediatr; 1985 Aug; 107(2):301-6. PubMed ID: 4020560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.